Opmizing Heart Failure Treatment in Pa ents Receiving Renal ReplacementTherapy: The Role of a Cardiorenal Unit
by Prateek Chopra | May 17, 2026 | Cardiology Conferences | ESC-HF 2026 Cardiorenal syndrome (CRS) remains a major therapeutic challenge, particularly in patients receiving renal replacement therapy, where evidence supporting guideline-directed Heart Failure (HF) therapies is limited. The management of these patients is often complicated by multiple comorbidities, fluid overload, and concerns regarding treatment tolerability and safety. This study aimed